GPT Healthcare Ltd

GPT Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.123.6 on 3 Feb 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a continuation of the stock’s underperformance relative to its sector and broader market indices.

GPT Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.123.6 on 3 Feb 2026, marking a significant downturn amid broader market volatility and company-specific performance concerns.

GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

GPT Healthcare Ltd’s shares plunged to a new all-time low of Rs.123.6 on 3 Feb 2026, marking a significant milestone in the stock’s extended period of decline. The hospital sector stock has underperformed both its sector peers and broader market indices, reflecting persistent pressures on its financial performance and investor sentiment.

GPT Healthcare Ltd, a key player in the hospital sector, has reported a mixed quarterly performance for the period ending December 2025, with record net sales overshadowed by deteriorating profitability and financial health indicators. The company’s financial trend has shifted from negative to very negative, signalling mounting challenges despite top-line growth.

GPT Healthcare Ltd., a small-cap hospital operator with a market capitalisation of ₹1,063.00 crores, reported a concerning deterioration in its Q3 FY26 financial performance, with net profit declining 11.61% quarter-on-quarter to ₹9.37 crores despite modest revenue growth. The company's shares have been under severe pressure, trading at ₹130.00 as of February 02, 2026, down 23.57% over the past year and significantly underperforming the hospital sector's 12.12% gain by a staggering 35.69 percentage points.

GPT Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 January 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating technical parameters, suggests increasing downside pressure amid a challenging market backdrop.

GPT Healthcare Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend, as reflected in recent market data and technical indicators. Despite a modest day gain of 2.71%, the stock’s overall technical outlook remains cautious, with mixed signals from key momentum and trend-following tools.

GPT Healthcare Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action and technical parameters suggest increasing downside pressure, reflecting broader challenges within the hospital sector and investor sentiment.

GPT Healthcare Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest day gain of 0.75%, the stock’s broader technical landscape reveals a complex interplay of bearish and bullish signals that investors should carefully analyse.

GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

GPT Healthcare has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor sentiment. The recent assessment highlights a complex interplay of factors including operational performance, valuation appeal, financial health, and technical market signals within the hospital sector.

GPT Healthcare's market evaluation has undergone a revision reflecting shifts in its financial and technical outlook. The recent assessment highlights a complex interplay of factors including valuation appeal, operational challenges, and market sentiment within the hospital sector.

GPT Healthcare Ltd., a small-cap hospital operator with a market capitalisation of ₹1,195 crores, reported a concerning decline in profitability for Q2 FY26, despite posting its highest-ever quarterly revenue. Net profit fell 28.49% quarter-on-quarter to ₹10.60 crores, whilst declining 28.48% year-on-year from ₹14.82 crores in Q2 FY25. The stock, trading at ₹147.35 as of November 7, 2025, has struggled throughout the year, declining 19.39% year-to-date and underperforming both the benchmark Sensex and its hospital sector peers by significant margins.